A detailed history of Ria Advisory Group LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Ria Advisory Group LLC holds 92,931 shares of KOD stock, worth $228,610. This represents 0.2% of its overall portfolio holdings.

Number of Shares
92,931
Holding current value
$228,610
% of portfolio
0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$3.01 - $7.45 $279,722 - $692,335
92,931 New
92,931 $489 Million
Q3 2023

Nov 14, 2023

SELL
$1.8 - $7.49 $199,632 - $830,693
-110,907 Reduced 91.53%
10,265 $18.5 Million
Q2 2023

Jul 25, 2023

BUY
$4.3 - $9.48 $198,384 - $437,369
46,136 Added 61.49%
121,172 $836 Million
Q1 2023

Apr 25, 2023

SELL
$4.81 - $8.88 $358,537 - $661,915
-74,540 Reduced 49.83%
75,036 $465 Million
Q4 2022

Feb 09, 2023

BUY
$6.52 - $8.05 $975,235 - $1.2 Million
149,576 New
149,576 $1.07 Billion

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $128M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Ria Advisory Group LLC Portfolio

Follow Ria Advisory Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ria Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ria Advisory Group LLC with notifications on news.